Rhythm Pharmaceuticals (RYTM) PT Raised to $35 at BofA Securities

January 27, 2021 8:39 AM EST
Get Alerts RYTM Hot Sheet
Price: $20.50 -3.62%

Rating Summary:
    6 Buy, 1 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 19 | Down: 18 | New: 47
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

BofA Securities analyst Tazeen Ahmad raised the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $35.00 (from $33.00) while maintaining a Neutral rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change